The global mastectomy implants market is worth US$ 2.09 Billion as of now and expected to reach US$ 4.69 Billion by the year 2033 at a CAGR of 8.4% between 2023 and 2033.
With cosmetic surgeries on the rise, the global mastectomy reconstruction implants market is expected to grow on an unstoppable note in the forecast period. On these grounds, Evonik, in November 2019, entered into collaborated with BellaSeno for tabling an advanced 3D-printed breast implant technology for enhancing patient’s quality of life post breast augmentation and reconstruction.
Besides, as per 2020 survey by the American Society of Plastic Surgeons, more than 65% of women suffering from breast cancer surgery were aware of breast reconstruction options prior to their surgery. It’s a noticeable increase since 2014 (was 61% then).
At the same time, increasing risk of complications in breast implant surgery is expected to restrain the mastectomy reconstruction implants market as women may ultimately prefer removing breast implants. The American Society of Plastic Surgeons (ASPS) states that overall complication rate related to breast reconstruction surgery is close to 10% (the most common complication being infection).
Future Market Insights has etched these facts with future prospects in its latest market study entitled ‘Masectomy Reconstruction Implants Market’. It has its team of analysts and consultants to execute using a bottom-up approach across macros and micros.
“With technologically advanced breast implants being readily available, the global mastectomy reconstruction implants market is likely to grow on a good note in the forecast period”, says an analyst from Future Market Insights.
